Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bioorthogonal chemistry for prodrug activation in vivo
Qunfeng Fu, Siyong Shen, Pengwei Sun, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 22, pp. 7737-7772
Closed Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Cleavage of Homonuclear Chalcogen‐Chalcogen Bonds in a Hybrid Platform in Response to X‐Ray Radiation Potentiates Tumor Radiochemotherapy
Yuanyuan You, Yanzhou Chang, Shuya Pan, et al.
Angewandte Chemie (2024) Vol. 137, Iss. 1
Open Access | Times Cited: 3
Acid-Responsive Polymer Micelles for Targeted Delivery and Bioorthogonal Activation of Prodrug through Ru Catalyst in Tumor Cells
Panpan Zhang, Leitao Zhang, Zhihao Wang, et al.
Biomacromolecules (2024) Vol. 25, Iss. 9, pp. 5834-5846
Closed Access | Times Cited: 3
Targeted Radionuclide Therapy Activates Prodrugs for Treating Metastasis
Zhibin Guo, Xuanyu Wang, Yi Han, et al.
ACS Central Science (2024) Vol. 10, Iss. 12, pp. 2321-2330
Open Access | Times Cited: 3
Nanozymes in cancer immunotherapy: metabolic disruption and therapeutic synergy
X Xu, Yaowen Zhang, Chijun Meng, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 37, pp. 9111-9143
Open Access | Times Cited: 2
Controlled bioorthogonal activation of Bromodomain-containing protein 4 degrader by co-delivery of PROTAC and Pd-catalyst for tumor-specific therapy
Zhiyao Li, Tai‐Bai Jiang, Yuan Xu, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 441-453
Closed Access | Times Cited: 2
Fluorogenic Tetrazine Bioorthogonal Probes for Advanced Application in Bioimaging and Biomedicine
Wuyu Mao, Ping Dong, Wei Du, et al.
Chemical & Biomedical Imaging (2024)
Open Access | Times Cited: 2
Discovery of new tetrazines for bioorthogonal reactions with strained alkenes via computational chemistry
Michal Májek, Matej Trtúšek
RSC Advances (2024) Vol. 14, Iss. 7, pp. 4345-4351
Open Access | Times Cited: 1
Advances in Bioinspired Artificial Systems Enabling Biomarker‐Driven Therapy
Meixia Wang, Huan Zhong, Yangbing Li, et al.
Chemistry - A European Journal (2024) Vol. 30, Iss. 48
Closed Access | Times Cited: 1
Triphenylamine Sensitized 8‐Dimethylaminoquinoline: An Efficient Two‐Photon Caging Group for Intracellular Delivery
Peter I. Dalko, Delphine Rigault, Philippe Nizard, et al.
Chemistry - A European Journal (2024)
Open Access | Times Cited: 1
NIR-Remote Selectively Triggered Buprenorphine Hydrochloride Release from Microneedle Patches for the Treatment of Neuropathic Pain
Huan-zhi Han, Bowen Li, Run Yang, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 8, pp. 5001-5013
Closed Access | Times Cited: 1
Gold(III)-Induced Amide Bond Cleavage In Vivo: A Dual Release Strategy via π-Acid Mediated Allyl Substitution
V. Unnikrishnan, Valerio Sabatino, Filipa Amorim, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 33, pp. 23240-23251
Open Access | Times Cited: 1
Drugs from drugs: New chemical insights into a mature concept
Eloy Lozano Baró, Federica Catti, Carolina Estarellas, et al.
Drug Discovery Today (2024), pp. 104212-104212
Open Access | Times Cited: 1
In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
Shaowen Xie, Jingjie Zhu, Yihan Peng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
Highly efficient and selective anticancer approach through acrolein-triggered cycloaddition chemistry in patient-derived xenografts: Mechanistic and preclinical investigation
Y Takahashi, Kazuki Terashima, Taiji Shimoda, et al.
Tetrahedron Chem (2024), pp. 100094-100094
Open Access
Bioorthogonal Chemistry-Based Prodrug Strategies for Enhanced Biosafety in Tumor Treatments: Current Progress and Challenges
Yongchao Yao, Ying Chen, Chang Chun Zhou, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 42, pp. 10818-10834
Closed Access
Sonocatalytic biomaterials
Kexing Li, Shuangshuang Wang, Chunmei Chen, et al.
Coordination Chemistry Reviews (2024) Vol. 522, pp. 216242-216242
Closed Access
Click‐and‐Release Formation of Urea Bonds in Living Cells Enabled by Micelle Nanoreactors
Léa Madegard, Mélissa Girard, Estelle Blochouse, et al.
Angewandte Chemie (2024)
Closed Access
In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
Shaowen Xie, Jingjie Zhu, Yihan Peng, et al.
Angewandte Chemie (2024)
Closed Access
Tumor Acidity‐Triggered Bioorthogonal Reactions for Biomedical Applications
Xiajian Liu, Ihsan Ullah, Youyong Yuan
ChemBioChem (2024) Vol. 25, Iss. 18
Closed Access
Light‐activated Nanocatalyst for Precise In‐situ Antimicrobial Synthesis via Photoredox‐Catalytic Click Reaction
Minyang Zhao, Lei Cao, Qingqing Bai, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 41
Closed Access
Mechanistic Insights into Chloride‐Dependent Uncaging Reaction of Propargyl and Allene‐Protected Substrates by Pd‐Complexes
Thuany M. Ferreira, Claudio D. Navo, Jonathan Paulo Agnes, et al.
Chemistry - A European Journal (2024) Vol. 31, Iss. 8
Closed Access
Previous Page - Page 2

Scroll to top